Urology · Olympia, WA
NPI
1043203771
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
402 Black Hills Ln SW, Suite A
Olympia, WA, 98502
Phone (360) 943-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$238K
7,103 services
Medicare patients, 2024
920
Average age 77
Drug cost, 2024
$170K
3,108 prescriptions
Company payments, 2025
$16.88
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel M Brown was code 81000 (clinical chemistry), 1,560 times for 890 patients. In total Daniel M Brown billed 7,103 services in 60 codes, and Medicare paid $238K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81000 Clinical Chemistry | Office | 1,560 | 890 | $3.85 | $6,002 |
| 51798 Ultrasound - Nonspecific | Office | 1,228 | 867 | $8.64 | $11K |
| 99213 Office E&M - Established | Office | 636 | 545 | $64.44 | $41K |
| 99214 Office E&M - Established | Office | 511 | 391 | $93.22 | $48K |
| 51702 Other Organ Systems | Office | 129 | 20 | $47.81 | $6,167 |
| 52000 Cystourethroscopy | Office | 115 | 89 | $195.38 | $22K |
| 99204 Office E&M - New | Office | 105 | 105 | $132.87 | $14K |
| 99215 Office E&M - Established | Office | 81 | 66 | $138.48 | $11K |
| 51741 Test - Miscellaneous | Office | 57 | 43 | $7.82 | $446 |
| 76872 Ultrasound - Nonspecific | Office | 39 | 37 | $115.59 | $4,508 |
| 55700 Other Organ Systems | Office | 35 | 33 | $191.22 | $6,693 |
| 76942 Ultrasound - Nonspecific | Office | 34 | 32 | $45.69 | $1,553 |
| 52224 Cystourethroscopy | Office | 18 | 15 | $643.50 | $12K |
| 52310 Calculus Removal - Urinary | Office | 13 | 11 | $260.53 | $3,387 |
| 51728 Other Organ Systems | Office | 13 | 12 | $276.85 | $3,599 |
By year: 2022 $249K for 7,086 services; 2023 $220K for 6,064 services; 2024 $238K for 7,103 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 1,560 | 890 | $3.85 | $6,002 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel M Brown prescribed most often to Medicare patients was Tamsulosin Hcl, with 982 prescriptions and refills. In total Daniel M Brown wrote 3,108 Medicare prescriptions that cost $170K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 982 | 2,725 | 303 | $23K |
| Dutasteride Generic | 699 | 1,997 | 216 | $28K |
| Finasteride Generic | 494 | 1,428 | 143 | $7,506 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 119 | 329 | 37 | $4,162 |
| Levofloxacin Generic | 99 | 99 | 89 | $302 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 64 | 64 | 60 | $294 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 61 | 81 | 35 | $1,081 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 45 | 49 | 31 | $714 |
| Potassium Citrate Er Potassium Citrate | 42 | 100 | 13 | $4,812 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 40 | 117 | 15 | $711 |
| Gemtesa Vibegron | 40 | 84 | 12 | $39K |
| Ciprofloxacin Hcl Generic | 40 | 40 | 39 | $723 |
| Methenamine Hippurate Generic | 39 | 73 | 17 | $3,623 |
| Myrbetriq Mirabegron | 33 | 91 | Under 11 | $41K |
| Cephalexin Generic | 31 | 31 | 28 | $184 |
Brand drugs: - claims; generic drugs: 3,014 claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel M Brown $16.88 ($16.88 in general payments such as food, travel and fees) from 1 company. The largest payer was Coloplast Corp with $16.88.
| Company | Payments | Amount |
|---|---|---|
| Coloplast Corp | 1 | $16.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.